Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 40
Filtrar
1.
J Drugs Dermatol ; 22(7): 692-693, 2023 07 01.
Artículo en Inglés | MEDLINE | ID: mdl-37410054

RESUMEN

Hidradenitis suppurativa (HS) is a painful, disfiguring, chronic inflammatory disease affecting the axillary, inframammary, and groin regions. Black Americans are disproportionately affected by HS. Structural barriers may be responsible for a lack of better prevention and management. This paper discusses possible reasons that may lead to a more severe presentation and barriers to treatment. Moseley I, Ragi SD, Handler MZ. racial disparities in the treatment of hidradenitis suppurativa: an analysis of data from the National Ambulatory Medical Care Survey. J Drugs Dermatol. 2023;22(7):692-694. doi:10.36849/JDD.6803.


Asunto(s)
Hidradenitis Supurativa , Humanos , Hidradenitis Supurativa/terapia , Hidradenitis Supurativa/tratamiento farmacológico , Negro o Afroamericano , Encuestas de Atención de la Salud , Ingle , Dolor
3.
Skinmed ; 16(5): 305-308, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30413223

RESUMEN

Patients with skin conditions may apply or consume a wide variety of "remedies" with a similarly wide range of effects that may alter the clinical and/or dermatologic presentations of the lesion. Dermatologists or other clinicians should probe for this and carefully document such treatment, as well as any treatment administered by a health care professional or any other person. The dermatopathologist, however, cannot assume that this has been done or done successfully, and therefore must be on constant alert to recognize the effects of such "remedies."


Asunto(s)
Errores Diagnósticos , Autocuidado/efectos adversos , Enfermedades de la Piel/patología , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad
5.
Int J Dermatol ; 57(4): 393-396, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-28369761

RESUMEN

Erythema ab igne (EAI) is a persistent, chronic skin condition resulting from prolonged exposure to infrared radiation, experienced as heat. Once associated with traditional warming sources like wood burning stoves or open fires, modern, infrared exposure originates also from newer sources like laptops and heating pads and may be creating a rebound of EAI. The epidemiology may be different too, with younger patients than previously seen. Localized EAI over an area of pain in the abdomen or lower back can be a sign of an underlying disorder, including cancer. Prognosis of EAI is good, with removal of the heat source resulting in complete remission. In chronic cases in which premalignant cutaneous dysplasia has resulted, additional treatments may be necessary including topical retinoids, 5-fluorouracil cream, and laser treatments. Rarely, cancers such as squamous cell carcinoma, Merkel cell carcinoma, and cutaneous marginal zone B cell lymphoma have been associated with longstanding EAI.


Asunto(s)
Eritema/etiología , Calor/efectos adversos , Rayos Infrarrojos/efectos adversos , Lesiones Precancerosas/etiología , Neoplasias Cutáneas/etiología , Abdomen , Dorso , Enfermedad Crónica , Eritema/terapia , Humanos , Pronóstico , Tecnología , Muslo
6.
Dermatol Surg ; 44(1): 61-67, 2018 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-28858927

RESUMEN

BACKGROUND: No studies have examined the use of topical ingenol mebutate for improvement of photoaged skin. OBJECTIVE: To evaluate clinical results of ingenol mebutate gel applied to photoaged skin and to quantify improvement at 7, 30, and 60 days after application. MATERIALS AND METHODS: Twenty-five subjects were enrolled in the study. Picato (ingenol mebutate) (LEO Pharma, Parsippany, NJ) gel was applied to an area with a known actinic keratosis daily for 3 days. Subjects self-evaluated and were investigator evaluated on 6 characteristics on Days 7, 30, and 60 using an objective scale. The scale evaluated actinic keratosis, overall skin appearance, wrinkling, dyschromia, erythema, and texture. The subjects were also evaluated using the Griffiths' Photonumeric Photoaging Scale for overall improvement. RESULTS: Twenty-two subjects completed the clinical study and demonstrated statistically significant improvement by Day 60 in actinic keratosis, overall skin appearance, wrinkling, dyschromia, erythema, and texture (p < .05). CONCLUSION: Topical ingenol mebutate 0.015% gel produces cosmetic improvement of photoaged skin within 60 days of application.


Asunto(s)
Fármacos Dermatológicos/administración & dosificación , Diterpenos/administración & dosificación , Queratosis Actínica/tratamiento farmacológico , Envejecimiento de la Piel/efectos de los fármacos , Anciano , Fármacos Dermatológicos/efectos adversos , Diterpenos/efectos adversos , Femenino , Geles , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Envejecimiento de la Piel/efectos de la radiación
7.
J Cosmet Dermatol ; 17(2): 232-234, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-28736885

RESUMEN

Squamous cell carcinoma (SCC) of the scalp has increased prevalence in older patients and often presents later in life. Mohs micrographic surgery remains the most effective treatment in most cases. Delayed presentation may result in localized bony invasion or distant metastases. We present a case of an elderly woman presenting with extension of SCC into the parietal bone of the skull.


Asunto(s)
Carcinoma de Células Escamosas/patología , Neoplasias de Cabeza y Cuello/patología , Hueso Parietal/patología , Cuero Cabelludo , Neoplasias Cutáneas/patología , Anciano de 80 o más Años , Carcinoma de Células Escamosas/cirugía , Femenino , Neoplasias de Cabeza y Cuello/cirugía , Humanos , Cirugía de Mohs , Invasividad Neoplásica , Hueso Parietal/diagnóstico por imagen , Tomografía Computarizada por Tomografía de Emisión de Positrones , Neoplasias Cutáneas/cirugía
12.
J Cosmet Dermatol ; 16(4): 450-453, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28752575

RESUMEN

BACKGROUND: Lasers and noncoherent intense pulse light sources effectively treat vascular lesions. Intense pulsed light (IPL), a nonablative treatment for photorejuvenation, uses a flashlamp which emits noncoherent light between 400 and 1400 nm. The light may be filtered to target a specific chromophore. The pulsed dye laser (PDL), at 595 nm, has been the historical standard of care in the treatment of facial erythema. We sought to determine whether IPL may be used in lieu of PDL in reducing facial erythema. OBJECTIVES: To determine whether IPL may be used to treat facial erythema with equal efficacy as PDL used at nonpurpuric settings. METHODS: Prospective investigation of a cohort of 15 subjects with unwanted bilateral facial erythema. Subjects presented for two treatments with an IPL (BBL™ BroadBand Light; Sciton, Palo Alto, CA) to one half of the face and PDL (Cynergy™; Cynosure, Westford, MA) to the other half. RESULTS: Patients with facial erythema may be successfully treated with IPL or PDL. CONCLUSIONS: Intense pulsed light and pulsed dye laser with nonpurpuric settings were equally effective in reducing facial erythema.


Asunto(s)
Eritema/terapia , Dermatosis Facial/terapia , Tratamiento de Luz Pulsada Intensa , Láseres de Colorantes/uso terapéutico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Método Simple Ciego
15.
Int J Dermatol ; 56(6): e106-e117, 2017 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-28321838

RESUMEN

Porphyrias are a group of intriguing genetic diseases of the heme pathway, of which porphyria cutanea tarda (PCT) is the most common. Resulting from a defect in enzymes in the porphyria pathway, PCT has been linked to several conditions. Recent studies have demonstrated a change in thinking regarding the human immunodeficiency virus (HIV) and development of PCT. The exacerbation of PCT with contraction of HIV is now believed to result from coinfection from the hepatitis C virus (HCV). Blistering of sun-exposed skin, a classic presenting sign of PCT, is not exclusive to the condition. Cutaneous findings must also trigger physicians to consider additional types of porphyrias, such as variegate porphyria. The diagnosis of pseudoporphyria, which does not result from enzymatic absence, must be considered in patients with photosensitivity and cutaneous bullae. Recent health food trends, such as chlorophyll, have been linked to pseudoporphyria. PCT is a serious condition in which accurate diagnosis is necessary for appropriate management.


Asunto(s)
Progresión de la Enfermedad , Porfiria Cutánea Tardía/diagnóstico , Porfiria Cutánea Tardía/enzimología , Diagnóstico Diferencial , Hemo/biosíntesis , Humanos , Porfiria Cutánea Tardía/genética , Porfiria Cutánea Tardía/terapia , Porfirias Hepáticas/diagnóstico , Factores de Riesgo
16.
J Am Acad Dermatol ; 77(1): 149-158, 2017 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-28314682

RESUMEN

Hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome is a rare genetic disorder that predisposes individuals to multiple cutaneous leiomyomas, renal cell carcinomas, and in women, uterine leiomyomas. Also known as Reed syndrome, it is caused by a germline heterozygous mutation of the fumarate hydratase tumor suppressor gene. HLRCC is associated with significant morbidity because of pain from cutaneous and uterine leiomyomas, the cutaneous pain often of unique character. Although genetic testing is currently considered the criterion standard to diagnose HLRCC, newer immunohistochemistry markers may provide rapid and cost effective alternatives to genetic testing. Because of the potentially aggressive nature of renal cell carcinomas that develop as early as in childhood, close annual cancer surveillance is desirable in individuals with HLRCC. In this review, we offer an update and an approach to the diagnosis, management, and renal cancer surveillance in HLRCC.


Asunto(s)
Leiomiomatosis/diagnóstico , Leiomiomatosis/terapia , Síndromes Neoplásicos Hereditarios/diagnóstico , Síndromes Neoplásicos Hereditarios/terapia , Neoplasias Cutáneas/diagnóstico , Neoplasias Cutáneas/terapia , Neoplasias Uterinas/diagnóstico , Neoplasias Uterinas/terapia , Algoritmos , Humanos
17.
Cutis ; 99(1): 33-36, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-28207011

RESUMEN

Onychomadesis is the proximal separation of the nail plate from the nail matrix due to a temporary cessation of nail growth. It can occur in children of all ages including neonates. Diagnosis is made clinically through palpation and inspection of the nail plate. Physicians should consider underlying associations. A review of the patient's history for any viral illnesses 1 to 2 months prior to nail changes often will help identify the causative disease. Onychomadesis typically is mild and self-limited. There is no specific treatment, but a conservative approach to management is recommended with treatment of any underlying causes and supportive care. Spontaneous nail regrowth usually occurs within 12 weeks and may occur faster in children. In this article, causes of onychomadesis are described, including the connection between hand-foot-and-mouth disease (HFMD) and onychomadesis. We also explore several theories of possible mechanisms for onychomadesis; however, the precise mechanism remains unclear and further investigation is needed.


Asunto(s)
Enfermedad de Boca, Mano y Pie/complicaciones , Enfermedades de la Uña/diagnóstico , Niño , Preescolar , Humanos , Lactante , Recién Nacido , Enfermedades de la Uña/etiología , Enfermedades de la Uña/patología , Factores de Tiempo
18.
Int J Dermatol ; 56(2): e19-e25, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27667734

RESUMEN

Since the beginning of the twenty-first century, there has been a rapid rise in the number of cases of chikungunya. Initially limited to islands of the southwestern Indian Ocean, the virus has spread across Africa and into the islands of the Caribbean. Cutaneous symptoms include a morbilliform eruption, hyperpigmented macules, and aphthae-like ulcers. Patients often also experience fever and joint pain. We review the methods for diagnosis, treatment, and prevention of this increasingly prevalent virus now emerging more commonly in Europe and North America.


Asunto(s)
Fiebre Chikungunya/diagnóstico , Fiebre Chikungunya/epidemiología , Aedes , Animales , Fiebre Chikungunya/terapia , Fiebre Chikungunya/transmisión , Europa (Continente)/epidemiología , Humanos , Mosquitos Vectores , América del Norte/epidemiología
19.
Skinmed ; 14(5): 372-373, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27871351
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...